Skip to main content

Table 1 Demographics and clinical characteristics in three Latin American populations at baseline

From: Efficacy of a fixed combination of 0.09 % xanthan gum/0.1 % chondroitin sulfate preservative free vs polyethylene glycol/propylene glycol in subjects with dry eye disease: a multicenter randomized controlled trial

 

Chile

 

Colombia

 

Mexico

 

XG/CS n = 32

PEG/PG n = 24

pa

XG/CS n = 26

PEG/PG n = 20

pa

XG/CS n = 94

PEG/PG n = 100

pb

Age, years

 Mean (SD)

38.6 (13.6)

35.3 (11.8)

0.336

52.9 (13.7)

52.7 (12.4)

0.824

50.8 (16.7)

48.3 (13.5)

0.273

Gender, N (%)

 Female

13 (81)

8 (67)

0.212

10 (77)

8 (80)

0.802

20 (77)

16 (80)

0.958

 Male

3 (19)

4 (33)

3 (23)

2 (20)

6 (23)

4 (20)

IOP, mmHg

 Mean (SD)

14.2 (2.5)

13.7 (1.2)

0.471

12.5 (2.3)

13.2 (1.6)

0.535

12.8 (2.5)

13.1 (2.4)

0.201

Schirmer test, mm/min

 Mean (SD)

6.2 (2.4)

7.1 (2.6)

0.114

6.0 (2.8)

6.3 (2.8)

0.674

6.8 (1.8)

6.2 (2.4)

0.233

TBUT, sec

 Mean (SD)

5.5 (1.3)

6.0 (1.8)

0.292

4.9 (2.0)

4.5 (2.0)

0.487

5.8 (2.2)

4.9 (1.9)

0.073

OSDI, score

 Mean (SD)

18.5 (6.6)

20.0 (9.2)

0.714

19.8 (7.9)

15.4 (2.4)

0.070

19.4 (6.9)

20.6 (7.4)

0.234

  1. XG/CS Xanthan gum/Chondroitin sulfate, PEG/PG Polyethylene glycol/Propylene glycol, IOP Intraocular pressure, TBUT Tear break-up time, OSDI Ocular Surface Disease Index. aWilcoxon T test. bPaired T test. p ≤ 0.05. n = total eyes